|
Reason(s) for PICU admission n (%)
|
Total PICU cohort (N = 30)
|
|---|
|
Hypoxia
|
15 (50)
|
|
Hemodynamic instability
|
6 (20)
|
|
DKA
|
2 (7)
|
|
Cardiac dysfunction
|
2 (7)
|
|
Mediastinal mass
|
2 (7)
|
|
Apnea
|
2 (7)
|
|
Acute chest syndrome in sickle cell disease
|
2 (7)
|
|
Other
|
6 (20)
|
|
Outcomes
|
|
Length of ICU stay, days [mean (median, IQR)]a
|
8.8 (3.6, 2.5–14.7)
|
|
ICU discharge (n, %)
|
29 (97)
|
|
Deceased (n, %)
|
1 (3)
|
|
Respiratory failure
|
Intubated cohort (N = 8)
|
|---|
|
OSI at intubation [mean (median, IQR)]
|
14 (15, 5.5–20)
|
|
Maximum PEEP [mean (median)]
|
12 (13.5)
|
|
Ventilator-free days [mean (median, IQR)]
|
14 (15, 13–23)
|
|
PICU admission characteristics
|
Total cohort (N = 30)
|
PICU low acuity (n = 16)
|
PICU organ dysfunction (n = 14)
|
|---|
|
pSOFA [mean (median, IQR)]
|
2.3 (1.0, 1.0–3.0)
|
0.6 (1.0, 0–1.0)
|
44 (3.0, 2.0–7.0)
|
|
PELOD-2 [mean (median, IQR)]
|
2.0 (2.0, 0–3.0)
|
0.6 (0, 0–2.0)
|
3.6 (3.5, 2.0–6.0)
|
|
System failure (n, %)b
|
|
Cardiovascular dysfunction
|
14 (47)
|
3 (19)
|
11 (79)
|
|
Respiratory dysfunction
|
9 (30)
|
0
|
9 (64)
|
|
Hematalogic dysfunction
|
6 (20)
|
0
|
6 (43)
|
|
Neurologic dysfunction
|
5 (17)
|
0
|
5 (36)
|
|
Hepatic dysfunction
|
5 (17)
|
2 (13)
|
3 (21)
|
|
Renal dysfunction
|
5 (17)
|
0
|
5 (36)
|
- aAmong survivors
- bSystem failure defined as pSOFA > = 1 for system category(18)
